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Summary
Sirtuin proteins comprise a unique class of NAD+-de-
pendent protein deacetylases. Although several struc-
tures of sirtuins have been determined, the mecha-
nism by which NAD+ cleavage occurs has remained
unclear. We report the structures of ternary complexes
containing NAD+ and acetylated peptide bound to the
bacterial sirtuin Sir2Tm and to a catalytic mutant
(Sir2TmH116Y). NAD+ in these structures binds in a con-
formation different from that seen in previous struc-
tures, exposing the a face of the nicotinamide ribose
to the carbonyl oxygen of the acetyl lysine substrate.
The NAD+ conformation is identical in both structures,
suggesting that proper coenzyme orientation is not
dependent on contacts with the catalytic histidine.
We also present the structure of Sir2TmH116A bound
to deacteylated peptide and 30-O-acetyl ADP ribose.
Taken together, these structures suggest a mecha-
nism for nicotinamide cleavage in which an invariant
phenylalanine plays a central role in promoting forma-
tion of the O-alkylamidate reaction intermediate and
preventing nicotinamide exchange.
Introduction
Sir2-like enzymes, also known as sirtuins, comprise a
universally conserved family of NAD+-dependent pro-
tein deacetylases that play important roles in transcrip-
tional regulation, fat mobilization, rDNA recombination,
metabolic regulation, and longevity (Luo et al., 2001).
Sirtuins contain a conserved enzymatic core comprising
a Rossmann fold domain and a small domain formed by
two insertions within the Rossmann fold. (Avalos et al.,
2002, 2004; Chang et al., 2002; Finnin et al., 2001; Min
et al., 2001; Zhao et al., 2003a, 2004). The Rossmann
fold domain and the small domain are separated by a
cleft in which NAD+ and the acetylated peptide substrate
bind. Biochemical studies of sirtuin activity show that
deacetylation occurs stoichiometrically with hydrolysis
of the glycosidic bond between nicotinamide and the ri-
bose of NAD+ to form a covalently boundO-alkylamidate
intermediate (Sauve et al., 2001; Smith and Denu, 2006).
Subsequent proton abstraction from and donation to
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release of the deactylated lysine, nicotinamide, and 20-
O-acetyl ADP ribose, which can esterify to 30-O-acetyl
ADP ribose (Jackson and Denu, 2002). Recent evidence
suggests that the acetylated ADP ribose products of the
sirtuin reaction may behave as second messengers
(Kustatscher et al., 2005; Liou et al., 2005).
Some sirtuin proteins have also been shown to behave
as mono ADP-ribosyltransferases (Tanny et al., 1999).
The trypanosomal enzyme TbSir2RP1 and human SirT6
both display ADP-ribosyltransferase activity in vitro
(Garcia-Salcedo et al., 2003; Liszt et al., 2005). The mech-
anism of ADP-ribosylation likely begins with the same
NAD+ cleavage step of the deacteylation reaction. How-
ever, it is not known whether an acetylated substrate is
necessary for sirtuin-catalyzed ADP-ribosylation, nor is
it known which substrate residue is modified. A thorough
understanding of the sirtuin reaction mechanism will be
necessary in order to elucidate the factors that promote
ADP-ribosylation by some sirtuins but not others.
Two different structure-based mechanisms for the
nicotinamide cleavage reaction have been proposed
(Avalos et al., 2002, 2004; Zhao et al., 2004). An associa-
tive, SN2-like mechanism was proposed for the first step
in sirtuin turnover based on the structure of an archael
sirtuin from Archeoglobis fulgidus, Sir2Af2, in complex
with NAD+ (Avalos et al., 2004). In this structure, NAD+
is bound in a ‘‘productive’’ conformation that buries
the nicotinamide ring in a conserved pocket known as
the C pocket (Min et al., 2001). The binding of NAD+ in
this conformation is prompted by the fortuitous binding
of a molecule of polyethylene glycol (PEG) in the active
site tunnel that is normally occupied by the acetyl lysine
substrate. When the acetyl lysine-containing peptide
from the structure of peptide bound Sir2Af2 (Avalos
et al., 2002) is modeled into the active site of the produc-
tive NAD+ structure, the acetyl lysine carbonyl is within
2.8 A˚ of the C10 position and is in the proper orientation
for nucleophilic attack. This NAD+ conformation buries
the positive charge on the nicotinamide ring in a con-
served hydrophobic pocket and disrupts the resonance
of the delocalized electrons of the nicotinamide ring
through distortion of the carboxamide moiety. These
two factors were proposed to cause ground state desta-
bilization of NAD+, thereby making nicotinamide a better
leaving group. A different, dissociative mechanism was
proposed based on the structure of the yeast sirtuin
Hst2 in complex with an acetylated histone H4 peptide
and carba-NAD+, a nonreactive NAD+ analog in which
the N-ribose oxygen is replaced by carbon, giving 2,3-di-
hydroxycyclopentane (Slama and Simmons, 1988; Zhao
et al., 2004). In the ternary complex with carba-NAD+, the
orientation of the dihydroxycyclopentane ring sterically
precludes direct nucleophilic attack by the acetyl lysine
carbonyl at the C10 position. Instead, it was postulated
that an ordered water molecule stabilizes a positively
charged oxocarbenium ion that would result from disso-
ciative cleavage of the glycosidic bond with nicotin-
amide. The ribose was proposed to then rotate and
undergo significant structural rearrangement to allow
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to formation of the O-alkylamidate intermediate.
Each proposed mechanism has features consistent
with enzymatic studies. Both models account for the
1:1 stochiometry of NAD+ bond breakage and deactey-
lation. Each model also maintains the stereochemistry
of the C10 position after resolution of the O-alkylamidate
intermediate. However, neither structure contains both
acetyl lysine and NAD+, which may adopt different con-
formations when bound in a ternary complex. First, the
cyclopentane moiety of carba-NAD+ cannot adopt the
ring puckers or participate in all of the hydrogen bonds
available to ribose. The conformation of carba-NAD+
may therefore not reflect the conformation of NAD+ in
the actual Michaelis complex. Second, the PEG mole-
cule seen in the productive conformations of Sir2Af2
bound to NAD+ is unable to hydrogen bond to the nico-
tinamide ribose hydroxyls in a manner similar to acetyl
lysine. The hydrophobic nature of PEG may repel the
ribose hydroxyls, thereby forcing NAD+ into a strained
conformation that does not occur when acetyl lysine is
present. Thus, both structures may allow NAD+ to adopt
conformations that are not present in a sirtuin/NAD+/
acetylated substrate ternary complex that is poised for
catalysis.
To help determine the conformation of NAD+ in a cata-
lytic ternary complex and to aid in elucidation of the
mechanism of sirtuin-catalyzed nicotinamide cleavage
and ADP-ribosylation, we have determined the structure
of wild-type Sir2Tm from the thermophilic bacterium
Thermatoga maritima bound to an acetylated p53 pep-
tide and NAD+. The unreacted ternary complex was
trapped by using crystals of Sir2Tm bound to acetylated
peptide that were soaked in NAD+ for short times. Lon-
ger incubation times yielded Sir2Tm bound to products,
demonstrating that the enzyme is active in the crystal,
and that the trapped, unreacted ternary complex may
reflect the Michaelis complex. The NAD+ in the wild-
type ternary complex structure adopts a conformation
that is different from those seen in either of the previ-
ously reported structures of sirtuins bound to NAD+
(Avalos et al., 2004) or carba-NAD+ (Zhao et al., 2004).
We also determined the structure of a ternary complex
with a Sir2Tm catalytic mutant in which the active site
histidine 116 was substituted with tyrosine. The struc-
ture of the mutant ternary complex is virtually identical
to that of the wild-type enzyme, indicating that the in-
variant histidine is not important for proper positioning
of NAD+ in the active site. In order to gain insight into
enzyme turnover, we determined the structure of a
Sir2TmH116A mutant in the presence of the reaction
products, deacetylated peptide and 30-O-acetyl ADP
ribose. The structures presented herein provide new in-
sights into the catalytic mechanism of NAD+-dependent
deacetylation as well as the structural rearrangements
that occur during enzyme turnover.
Results
Structure of Sir2TM Bound to NAD+
and an Acetylated Peptide
The structure of the bacterial sirtuin Sir2Tm in complex
with NAD+ and an acetylated p53 peptide, which is an
in vitro substrate for the enzyme, was determined ata resolution of 2.0 A˚ (Table 1). Ternary complex crystals
were obtained by soaking crystals of Sir2Tm bound to
acetylated p53 peptide in a cryopreservative containing
10 mM NAD+ (see Experimental Procedures). A single
molecule of NAD+ was apparent in crystals soaked for
30 min to 4 hr before being flash frozen. Crystals soaked
for shorter times displayed low occupancy of NAD+ in
the active site (data not shown), while soaks of a longer
duration led to enzymatic turnover (see below). The rep-
resentative structure described here was obtained from
crystals soaked for 2 hr prior to flash freezing.
The overall structure of TmSir2 bound to p53 peptide
and NAD+ is similar to that of previously reported struc-
tures of sirtuins bound to peptide (Figure 1A) (Avalos
et al., 2002, 2005; Zhao et al., 2003a, 2003b, 2004). The
electron density is well defined for most of the enzyme’s
polypeptide chain, with the exception of residues 36–42,
which comprise a flexible loop that is disordered in sev-
eral sirtuin structures (Avalos et al., 2002, 2005; Zhao
et al., 2003a). The overall structure of the ternary com-
plex has a root-mean-square deviation (rmsd) of 0.33 A˚
for Ca atoms compared with the structure of Sir2Tm
bound to the identical peptide in the absence of NAD+
(Avalos et al., 2005). As seen previously, Sir2Tm binds







Space group P212121 P212121
Unit cell (A˚) 45.8, 59.3, 106.7 46.1, 59.7, 107.4
Resolution (A˚) 2.0 50–2.1
Measured reflections 133,218 123,486
Unique reflections 20,048 17,933
Completeness (%) 98.7 (91.1) 99.9 (100)
Average I/s (merged data) 21.1 (3.9) 20.3 (3.7)
Multiplicity 6.6 (4.5) 6.9 (4.5)
Mosaicity 0.68 0.68
Rsym
a (%) 10.2 (29.0) 9.2 (48.2)
Refinement Statistics
Resolution range (A˚) 50–2.0 50–2.1
Reflections (I/s > 0) 20,000 16,973
Working set 18,976 16,107
Test set (5.0%) 1,024 866
Total atoms
Protein monomers 1 [29.73] 1 [28.47]
Residues of p53 peptide 8 [42.57] 11 [55.12]
NAD+ molecules 1 [26.56] —
O-acetyl ADP ribose — —
Zn2+ atoms 1 1
Water molecules 96 [38.85] 138 [36.12]
R factorb (%) 18.4 19.7
Rfree
c (%) 22.5 24.6
Overall B factor (A˚2) 31.1 31.0
Rmsd
Bond lengths (A˚) 0.017 0.018
Bond angles () 1.73 1.74
Values in parentheses correspond to the highest-resolution shell.
Values in brackets correspond to B factors in A˚2 for the given atoms.
a Rmeas as described by Diederichs and Karplus (1997).
b R factor 2 SjFoj 2 jFcj/SjFoj where Fo is the amplitude of the ob-
served structure factor, and Fc is the structure factor calculated
from the model.
c Rfree is the R factor calculated with 5% of the reflection data ran-
domly omitted from the refinement.
Complexes of Sir2Tm-Acetylated Peptide-NAD+
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Sir2Tm Bound to Acetylated Peptide and
NAD+
(A) Overall structure of Sir2Tm bound to an
acetylated peptide corresponding to resi-
dues 372–389 of the p53 protein (yellow)
and b-NAD+ (gray). The Sir2Tm Rossmann
fold domain, the a-helical subdomain and
Zn binding subdomain, and the Zn atom are
colored teal, blue, and gold, respectively.
(B) Electron density for the sirtuin substrates.
The 2Fo2 Fc electron density map contoured
at 1s is shown surrounding the acetylated
p53 peptide (yellow) and b-NAD+ bound to
the active site of Sir2Tm.
(C) Stereodiagram of NAD+ (white) in the ac-
tive site of Sir2Tm (teal) bound to acetylated
peptide (yellow). Active site residues that
make contact with NAD+ are shown as lines,
the acetyl lysine substrate and NAD+ are
shown as sticks, and water contacts are
shown as dashed, gray sticks.
(D) Schematic representation of Sir2Tm con-
tacts with NAD+ and acetyl lysine. Sir2Tm
residues are shown as ovals containing the
amino acid designation and number; invari-
ant residues shaded in blue, waters are
shown as red circles, and the acetyl lysine
side chain is designated as Ac-K and shaded
yellow. Hydrogen bonds between NAD+ and
backbone amides and carbonyls are shown
as blue and red dashes, respectively. Hydro-
gen bonds to amino acid side chains are
represented as green dashes, and van der
Waals interactions are indicated by yellow
semicircles.the p53 peptide by forming backbone hydrogen bonds
with loops flanking the peptide binding cleft, giving rise
to a three-stranded enzyme-substrate b sheet, with the
peptide as the central strand. This b sheet structure ori-
ents the acetyl lysine of the peptide substrate in a large
hydrophobic cleft.
NAD+ binds in the substrate binding cleft adjacent to
the acetyl lysine side chain. The NAD+ molecule is well
ordered and is present at high occupancy, as judged
by its well-defined electron density and an average B
factor of 27 A˚2, which is close to that of the average B fac-
tor of 22 A˚2 for the protein atoms (Figure 1B). The adenine
ring of NAD+ forms extensive hydrogen bond and van der
Waals interactions with the Rossmann fold domain,
forming essentially identical contacts to those seen in
other complexes of sirtuins with NAD+ (Figures 1C and
1D) (Avalos et al., 2004; Chang et al., 2002; Min et al.,
2001; Zhao et al., 2003b, 2004). At the other end of the
binding cleft, the nicotinamide ring is positioned in a
hydrophobic pocket, known as the C pocket, and forms
hydrogen bond interactions that rotate the carboxamide
w150 from its preferred coplanar conformation with the
nicotinamide ring. The positioning of nicotinamide in the
C pocket and the rotation of the carboxamide group are
similar to what has been observed in the structure ofSir2Af2 bound NAD+ in the ‘‘productive’’ conformation
(Avalos et al., 2004) as well as in the structure of Hst2
bound to carba-NAD+ (Zhao et al., 2004).
In contrast with the conserved binding of the nicotin-
amide and adenine moieties of NAD+, the N-ribose is
positioned in an orientation that differs from that of pre-
vious structures. In the structure of Hst2 bound to acet-
ylated peptide and carba-NAD+ (Zhao et al., 2004), the
acetyl lysine is oriented toward the b face of the nicotin-
amide cyclopentane and hydrogen bonds with the cy-
clopentane hydroxyls. However, in the complex of
TmSir2 bound to acetylated peptide and NAD+, the ri-
bose is rotated w30 around the glycosidic bond with
nicotinamide as compared with the position of cyclo-
pentane in the Hst2 structure. In this orientation, the
a face of the ribose sugar is oriented toward the acetyl
lysine carbonyl. This conformation of the N-ribose is
also distinct from that seen in the structure of Sir2Af2
bound to NAD+ in the productive conformation (Figure 2).
Although the a face of the N-ribose faces the acetyl ox-
ygen in the Sir2Af2 structure, the nicotinamide ribose is
rotated even farther from the position of cyclopentane in
the carba-NAD+ structure. The different position of the
N-ribose in the Sir2Af2 structure, which lacks acetylated
peptide, is consistent with a role for the acetyl oxygen in
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Analog Bound Sirtuin Structures
Structural alignment of Sir2Tm-acetylated
p53 peptide-NAD+ (blue), Hst2Sc-acetylated
histone H4 peptide-carba-NAD+ (green), and
Sir2Af2-NAD+ (pink) based on atoms in the
adenine ring, adenine ribose, nicotinamide,
and the catalytic histidine. Acetyl lysine and
active site residues for the corresponding
structures are indicated.orienting the N-ribose, as seen in the Sir2Tm/NAD+/
peptide ternary complex reported here.
In the structure of the wild-type Sir2Tm/NAD+/peptide
ternary complex, the N-ribose adopts a conformation
that allows the 20 and 30 hydroxyls to form hydrogen
bonds with both the carbonyl oxygen of the acetyl lysine
and His116. In addition, the 20 hydroxyl of the N-ribose
forms hydrogen bonds with an ordered water molecule
that is positioned by interactions with the side chain of
Gln99, a phosphate oxygen, the backbone amide of
Ala22, and the backbone carbonyl of Asn98. The posi-
tion of NAD+ in the ternary structure orients the ribose
a face toward the acetyl lysine substrate, placing the
C10 carbon 3.2 A˚ from the carbonyl oxygen. This posi-
tioning would allow for nucleophilic attack of the C10
atom from the a face of the N-ribose by the carbonyl
oxygen of acetyl lysine. Interestingly, the side chain of
invariant residue Phe33 is directly above the ribose oxy-
gen, placing this atom 3.0–4.4 A˚ from the center of the
side chain pi-electron cloud. The orientation and dis-
tance are similar to those observed in enzymes that
stabilize carbocation transition states via cation-pi inter-
actions (Zhu et al., 2003). This phenylalanine is also in
a position to shield the glycosidic bond and the oxacar-
benium transition state from water.
Deacetylation Occurs in Sir2Tm Ternary Crystals
The presence of the unreacted substrate in crystals
with wild-type Sir2Tm raises the possibility that this
structure may represent a catalytically inactive complex.
To address this issue, we determined the structure of
a Sir2Tm-acetylated peptide crystal soaked in the pres-
ence of NAD+ for 16 hr. During the time course of the
NAD+ soak, there was no change in crystal size or mor-
phology. The diffraction quality, unit cell dimensions,
and space group of crystals soaked for 16 hr were iden-
tical to those of the ternary complex crystals, which had
been soaked for just 2 hr (Table 1). The overall structure
of Sir2Tm in the crystal soaked for 16 hr was identical to
that of the unreacted ternary complex, with an rmsd for
Ca atoms of 0.29 A˚. However, inspection of the active
site electron density indicates that the acetyl group had
been removed from the lysine side chain bound in the hy-
drophobic pocket (Figure 3). When acetyl lysine is mod-
eled into the active site, the resulting Fo 2 Fc electron
density maps show strong negative density surrounding
the acetyl group (data not shown). There is also no longer
strong electron density corresponding to bound NAD+.
Instead, weak electron density, likely corresponding to
ADP ribose and nicotinamide, is present in the activesite. Due to the low occupancy of these products, con-
clusions regarding their orientation cannot be made
from this structure. Nevertheless, the finding that cata-
lytic turnover can occur in the crystals when incubated
for longer times indicates that the structures of ternary
complexes captured during shorter soaks likely repre-
sent true Michaelis-Menten complexes.
NAD+ Orientation Is Not Dependent
on Contacts with His116
The rate at which sirtuins catalyze NAD+-dependent de-
acetylation is dependent on the invariant residue, His116
(Sir2Tm numbering). His116 is proposed to abstract
a proton from either the 20 or 30 N-ribose hydroxyl, allow-
ing for resolution of the O-alkylamidate intermediate to
the products: lysine, 20-O-acetyl ADP ribose, and nicotin-
amide (Chang et al., 2002; Jackson et al., 2003; Sauve
et al., 2001; Smith and Denu, 2006). Mutation of this his-
tidine residue in sirtuin homologs leads to decreased
enzymatic turnover in vitro (Jackson et al., 2003) and
loss of transcriptional silencing in vivo (Tanny et al.,
1999). Kinetics studies examining the pH dependence
of sirtuin activity suggest that this histidine plays a key
role in binding and positioning NAD+ into its productive
Figure 3. Deacetylation Occurs in Sir2Tm-Acetylated Peptide Crys-
tals Soaked with NAD+
The structure of the Sir2Tm active site from a crystal grown in the
presence of acetylated p53 peptide and soaked for 16 hr in cryopro-
tectant containing 2 mM NAD+. The 2Fo 2 Fc electron density map
contoured at 1s clearly reveals that deacetylation of the substrate ly-
sine (yellow) has occurred. The 2Fo 2 Fc map surrounding His116
(gray) of the Rossmann fold (teal) is shown for comparison.
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Sir2Tm
(A) Effect of varying concentrations of acety-
lated p53 peptide on the deacetylation activ-
ity of Sir2Tm (closed circle), Sir2TmH116A
(open circle), and Sir2TmH116Y (closed trian-
gle) monitored by NAD+ consumption. Bars
represent the average error for three inde-
pendent experiments. Curves represent
best fits to the Michaelis-Menten equation
with a Km = 77 6 18 mM and a Vmax = 37.1
mM/min for Sir2Tm and a Km = 138 6 54 mM
and a Vmax = 16.1 mM/min for Sir2Tm
H116A.
Data for Sir2TmH116Y could not be fit to the
Michaelis-Menten equation and are repre-
sented by a straight line.
(B) Stereorepresentation of the active site of
Sir2TmH116Y-acetylated peptide-NAD+ (yel-
low) structurally aligned with that of the
ternary complex for the wild-type protein
(gray). Amino acid side chains from Sir2Tm
are designated by their one-letter code and
chain number and are shown as lines. NAD+
and the acetyl lysine side chain from each
structure are shown as sticks. Distances
from the acetyl lysine side chain carbonyl to
the N-ribose C10 position as well as hydrogen
bonds to the 20 and 30 N-ribose hydroxyls are
shown as dashes.conformation (Smith and Denu, 2006). In the ternary com-
plex structure of Sir2Tm bound to acetylated peptide and
NAD+, His116 is within hydrogen bonding distance of
both N-ribose hydroxyls and may help orient the a face
of the N-ribose toward the acetyl lysine side chain.
To address whether the invariant catalytic histidine is
important for the positioning of NAD+ in the active site of
Sir2Tm, we constructed two different mutant proteins
with substitutions at this site, H116Y and H116A, which
have been shown to decrease sirtuin activity in vivo and
in vitro, respectively (Jackson et al., 2003; Tanny et al.,
1999). Consistent with previously published reports,
both mutant proteins display decreased deacetylation
rates in vitro (Figure 4A). Sir2TmH116A shows a 2-fold de-
crease in turnover and peptide affinity compared to the
wild-type protein, as assayed by monitoring NAD+ con-
sumption at different concentrations of acetylated p53
peptide. The H116Y mutation displays an even greater
decrease in activity, retaining only w10% of the wild-
type protein activity when assayed at a 1 mM peptide
concentration. However, the overall decrease in activity
for both mutants was less dramatic than that observed
for similar mutations reported for other sirtuin homologs
(Jackson et al., 2003; Tanny et al., 1999). We took advan-
tage of the lower activity of the H116Y mutant to address
the role of the catalytic histidine in the conformation of
NAD+ in the active site. Crystals of a ternary complex
with the Sir2TmH116Y mutant were produced according
to the same method as the wild-type complex and
were isomophorous to the wild-type crystals.
The Sir2TmH116Y ternary complex structure, which
was determined at a resolution of 2.0 A˚ (Table 2), super-
imposes with the wild-type structure with an rmsd of
0.51 A˚ for all protein atoms and 0.48 A˚ for Ca atoms.
As found in the wild-type ternary complex structure,NAD+ is present at high occupancy, with an overall B fac-
tor of 21 A˚2. Interestingly, the position of NAD+ in the mu-
tant active site is nearly identical (rmsd of 0.39 A˚) to that
of the wild-type structure (Figure 4B) even though Tyr116
cannot form the same hydrogen bonds with the ribose as
does His116 in the wild-type complex. In both wild-type
and mutant ternary complex structures, the nicotin-
amide ribose is positioned with the a face oriented to-
ward the acetyl lysine, placing the C10 atom 3.2 A˚ from
the carbonyl oxygen. In addition, the acetyl lysine side
chain carbonyl is within hydrogen bonding distance of
both N-ribose hydroxyls. There is a slight difference be-
tween the nicotinamide ribose in the two structures, and
the sugar pucker of the N-ribose in Sir2Tm is slightly
more planar than in the mutant. Taken together, these
observations indicate that the invariant histidine does
not play a role in orientating NAD+ in the active site of
Sir2Tm. This hypothesis is consistent with enzymatic
studies on the yeast sirtuin Hst2, in which nicotinamide
cleavage occurs at approximately the wild-type rate in
a mutant containing substitution of the catalytic histidine
(Jackson et al., 2003). These results also suggest that the
acetyl lysine side chain and the side chain of Phe33,
which is positioned above the N-ribose oxygen, may
aid in positioning NAD+ for catalysis. Consistent with
this idea, mutagenesis studies on the corresponding
phenylalanine in yeast Sir2 (Sir2 residue 274) result in
a decrease in deacetylation activity in vitro and transcrip-
tional silencing in vivo (Armstrong et al., 2002).
Crystal Structure of Sir2Tm Bound
to Reaction Products
We have determined the structure of a mutant Sir2Tm
bound to the deacetylated peptide, O-acetyl ADP ri-
bose, and nicotinamide reaction products. The structure
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Sir2TmH116A, in the presence of NAD+ and acetylated
peptide. The crystallization conditions for this complex
are different (see Experimental Procedures) than those
used for the substrate soaking experiments described
previously and were dependent on the presence of acet-
ylated peptide and NAD+. Crystals grown under these
conditions form in a primitive tetragonal space group
and contain two molecules of Sir2TmH116A per asymmet-
ric unit that are identical to one another (molecules A and
B) (Figure 5A), superimposing with an rmsd of 0.09 A˚ for
Ca atoms.
The electron density in the active site of both com-
plexes shows clearly that the peptide is deacetylated
and that NAD+ has been cleaved. Molecule A is bound
to 30-O-acetyl ADP ribose (Figure 5B), and molecule B
is bound to ADP ribose (Figure 5C). The occupancy for
the acetyl group of the 30-O-acetyl ADP ribose is set to
50%, indicating that molecule A is likely bound to a mix-
ture of 30-O-acetyl ADP ribose and ADP ribose. Due to
the strong structural similarity between molecules A
and B in the crystal and the fact that ADP ribose and
30-O-acetyl ADP ribose are bound in identical conforma-
tions, we will discuss only the interactions with 30-O-
acetyl ADP ribose.







Space group P212121 P41
Unit cell (A˚) 45.3, 58.7, 106.9 47.0, 47.0, 257.1
Resolution (A˚) 2.0 50–1.9
Measured reflections 134,676 314,002
Unique reflections 20,058 42,845
Completeness (%) 99.4 (94.9) 97.9 (98.2)
Average I/s (merged data) 41.3 (8.9) 30.6 (5.2)
Multiplicity 6.7 (5.5) 7.3 (7.2)
Mosaicity 0.7 0.38
Rsym
a (%) 9.9 (40.2) 7.3 (36.7)
Refinement Statistics
Resolution range (A˚) 50–2.0 50–1.9
Reflections (I/s > 0) 18,900 42,803
Working set 17,895 40,635
Test set (5.0%) 1,015 2,168
Total atoms
Protein monomers 1 [23.82] 2 [34.12; 34.14]
Residues of p53 peptide 8 [31.00] 6 [42.76; 43.71]
ADP ribose molecules 1 [20.65] 1 [25.38]
O-acetyl ADP ribose — 1 [25.21]
Zn2+ atoms 1 2
Water molecules 103 [33.63] 215 [40.05]
R factorb (%) 19.5 20.5
Rfree
c (%) 23.7 24.7
Overall B factor (A˚2) 24.4 34.6
Rmsd
Bond lengths (A˚) 0.0056 0.019
Bond angles () 1.22 2.0
Values in parentheses correspond to the highest-resolution shell.
Values in brackets correspond to B factors in A˚2 for the given atoms.
a Rmeas as described by Diederichs and Karplus (1997).
b R factor 2 SjFoj 2 jFcj/SjFoj where Fo is the amplitude of the ob-
served structure factor, and Fc is the structure factor calculated
from the model.
c Rfree is the R factor calculated with 5% of the reflection data ran-
domly omitted from the refinement.As seen for NAD+ in the ternary complex of sirtuin sub-
strates, the adenine ring of 30-O-acetyl ADP ribose forms
extensive interactions with residues of the Rossmann
fold domain (Figure 5D). A striking finding, however, is
that the N-ribose of NAD+ undergoes a significant
change in position upon cleavage of the glycosidic
bond to nicotinamide. A rotation around the bond be-
tween the N-ribose phosphate and oxygen rotates the
C5 group by w100 (Figure 5E). This, in turn, rotates
the ribose relative to the NAD+ structure, allowing it to
make contacts with conserved residues in the flexible
loop. Specifically, the side chain of Arg34 moves 2 A˚ rel-
ative to its position in the bisubstrate structure and
forms a hydrogen bond to the ribose ring oxygen.
Tyr40, which is unstructured in the substrate ternary
complex, is highly ordered and forms a hydrogen bond
to the 10 hydroxyl. In addition, Phe33 rotates from its po-
sition above the N-ribose ring in the substrate complex
to an orientation adjacent to the ribose C10. In this orien-
tation, the side chain of Phe33 occludes the enzyme C
pocket from the bound O-acetyl ADP ribose. The posi-
tion of Phe33 is similar to that seen in the structure of
Sir2Tm bound to nicotinamide and has been proposed
to prevent the back reaction of nicotinamide with an en-
zyme bound O-alkylamidate intermediate (Avalos et al.,
2005). Thus, the conformational flexibility of this invari-
ant phenylalanine residue may play a critical role in sev-
eral aspects of the sirtuin reaction.
Discussion
The ternary complex structure of a wild-type sirtuin
bound to both an acetylated peptide and NAD+ makes
it possible to resolve central questions regarding the
mechanism of NAD+-dependent deacetylation, as well
as elucidate the role of several key invariant residues
that were known to be required for catalytic activity. A
key observation is that NAD+ in the wild-type ternary
complex is bound in a conformation that is distinct
from those seen in structures of NAD+ bound to wild-
type enzyme (Avalos et al., 2004) or in a ternary complex
containing an NAD+ analog (Zhao et al., 2004). The rela-
tive juxtaposition of the peptide and NAD+ cosubstrates
in this catalytically active complex makes it possible to
distinguish among different proposals for the enzymatic
reaction and provides important new insights into the
deacetylation mechanism. In particular, we find that
NAD+ is bound in a conformation in which the acetyl
lysine substrate is in position to carry out nucleophilic
attack on the a face of the nicotinamide ribose at the
C10 position, consistent with previous findings (Sauve
et al., 2001; Sauve and Schramm, 2003). The precise
conformation of NAD+, acetyl lysine, and the surround-
ing residues in the active site depend on one another,
consistent with prior observations that NAD+ cleavage,
deacetylation, and the inhibitory base-exchange reac-
tion depend on the presence of all three reaction constit-
uents (Jackson et al., 2003). The fortuitous trapping of
a wild-type ternary complex prior to chemical reaction
has therefore allowed us to determine the likely struc-
ture of the Michaelis complex and distinguish among
several models for catalysis.
A second set of observations comes from enzymatic
and structural studies described here of proteins with
Complexes of Sir2Tm-Acetylated Peptide-NAD+
1237Figure 5. Crystal Structure of the Sir2TmH116A Mutant Bound to Deacetylation Reaction Products
(A) Structural alignment of 30-O-acetyl ADP ribose bound (purple) and ADP ribose bound (green) Sir2TmH116A with the Sir2Tm ternary complex
(blue).
(B and C) 2Fo 2 Fc electron density maps contoured at 1s reveal that Sir2Tm
H116A structures contain deacetylated peptide and either (B) 30-O-
acetyl ADP ribose or (C) ADP ribose.
(D) Schematic representation of Sir2TmH116A contacts with 30-O-acetyl ADP ribose. Sir2Tm residues are shown as ovals containing the amino
acid designation and number; invariant residues are shaded in blue, and residues whose contacts with 30-O-acetyl ADP ribose differ from
NAD+ are designated with red lettering. Waters are shown as red circles. Hydrogen bonds between NAD+ backbone amides and carbonyls
are shown as blue and red dashes, respectively. Hydrogen bonds to amino acid side chains are represented as green dashes, and van der Waals
interactions are indicated by yellow semicircles.
(E) Stereorepresentation of a Ca alignment of the substrate (blue) and the product (purple) complexes with NAD and 30-O-acetyl ADP ribose
shown as blue and magenta sticks, respectively. Side chains of active site residues are designated by their one-letter amino acid designation
and number and are shown as sticks and lines for the product and substrate structures, respectively.substitutions of His116 (Sir2Tm numbering), an invariant
sirtuin residue that has been the subject of numerous
previous studies (Jackson et al., 2003; Smith and
Denu, 2006; Tanny et al., 1999). In contrast with previous
characterizations of this residue as being essential for
the deacetylation reaction, we find that Sir2Tm enzymes
with substitutions at this position simply show dimin-
ished deacetylation activity, with the precise level de-
pendent on the nature of the substitution. Particularly
surprising is the finding that a substitution of alanine
for His116 reduces enzymatic activity only about 2-
fold, while substitution with tyrosine reduces activity
w10-fold. The invariant histidine does not seem to be
important for positioning NAD+ or the peptide for the ini-
tial NAD+ cleavage reaction, as we find that a ternary
complex structure bound to the His116/Tyr mutant
shows no difference in NAD+ or acetyl lysine conforma-
tion. Rather, the histidine is likely needed as a general
base in later reaction steps (Jackson et al., 2003), as de-
scribed further below.
The findings reported here, taken together with previ-
ous structures (Avalos et al., 2004; Min et al., 2001; Zhao
et al., 2004), allow us to clarify and elaborate upon the
previously proposed structure-based mechanisms (Fig-
ure 6) (Avalos et al., 2004; Zhao et al., 2004). Prior studies
(Jackson and Denu, 2002; Sauve et al., 2001) have eluci-
dated a series of enzymatic steps, beginning with break-
age of the glycosidic bond with nicotinamide, reaction ofthe C10 of the N-ribose with the acetyl oxygen to form an
O-alkylamidate intermediate, and resolution of the inter-
mediate that leads to transfer of the acetyl group to the 20
OH of ADP ribose. The Sir2-catalyzed reaction begins
with binding of the two cosubstrates. NAD+ can bind to
the enzyme in a variety of conformations (Avalos et al.,
2004; Min et al., 2001; Zhao et al., 2004); its adenine
ring is fixed by binding to the Rossmann fold domain,
while its nicotinamide ring, adjacent ribose, and phos-
phates are free to adopt a number of different conforma-
tions. It is the binding of acetylated peptide and the inser-
tion of acetyl lysine into its binding tunnel that positions
NAD+ for the initial cleavage reaction (Avalos et al., 2004).
As seen in structures of sirtuins bound to NAD+ and PEG
(Avalos et al., 2004) or carba-NAD+ and acetylated pep-
tide (Zhao et al., 2004), occupancy of the acetyl lysine
binding tunnel promotes burial of the nicotinamide ring
in the C pocket. This is proposed to destabilize the glyco-
sidic bond between nicotinamide and the adjacent N-
ribose in two ways (Avalos et al., 2004). First, the
positively charged nicotinamide ring is buried within
the enzyme’s hydrophobic C pocket. In addition, the
nicotinamide carboximide is rotated w150 away from
its low-energy coplanar conformation (Li and Goldstein,
1992), potentially disrupting electronic resonance with
the ring and hence distribution of the positive charge.
These two factors favor cleavage of the already labile
glycosidic bond between nicotinamide and N-ribose.
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(I) Sirtuin binding of an acetylated peptide substrate and NAD+ places the nicotinamide ring into the hydrophobic C pocket of the enzyme and
exposes the a face of the N-ribose to the acetyl lysine carbonyl. As nicotinamide begins to disassociate to remove the positive charge buried in
the C pocket, the carbonyl oxygen is drawn to the electrodefecient C10 position, forming the O-alkylamidate intermediate. (II) As this occurs, the
pi-electron cloud of the side chain of Phe33 acts to stabilize the migrating positive charge and provides a hydrophobic shield to prevent water-
mediated attack at the C10 position. Upon cleavage of the glycosidic bond, Phe33 rotates to a position that prevents reformation of NAD+ and
thereby slows nicotinamide exchange. (III) His116, acting as a base, abstracts a proton from either the 20 or 30 (shown here) hydroxyl, activating
the 20 oxygen to attack the positive charge that is now buried in the hydrophobic tunnel, forming the cyclic amino-acetal intermediate. (IV) His116,
now acting as an acid, protonates the amino-acetal intermediate. (V) The amide bond is then cleaved to form a cyclic acyl-oxonium ion.
(VI) Water-mediated attack on this intermediate, likely from the activated water in the active site, and subsequent proton abstraction by the
amine of the (VII) lysine substrate side chain and (VIII) 10 oxygen resolve the cyclic acyl-oxionium and yield (IX) 20-O-acetyl ADP ribose.The actual breakage of the glycosidic bond and trans-
fer of ADP ribose to the acetyl group appears most likely
to occur by a reaction mechanism called nucleophilic
displacement by electrophile migration, as has been
proposed for the ADP-ribosylation reaction catalyzed
by diphtheria toxin (Parikh and Schramm, 2004). As the
glycosidic bond between nicotinamide and the N-ribose
is broken, positive charge character is transferred from
the hydrophobic environment of the C pocket to the
C10 position of the N-ribose, generating a transition state
with oxacarbenium character. We see no residues in
the vicinity of the C10 atom that could stabilize this tran-
sition state, either through interaction with a negatively
charged side chain or by formation of a covalent inter-
mediate with the enzyme. It appears most likely that
migration of the positive charge from the nicotinamide
to the N-ribose is accompanied by a lengthening of the
glycosidic bond and movement of the ribose that allows
for capture of the oxacarbenium transition state by the
carbonyl oxygen of acetyl lysine. In the structure of theternary complex between Sir2Tm, NAD+, and acetylated
peptide, the carbonyl of acetyl lysine is 3.2 A˚ from the
C10 position of the ribose a face. As the bond to nicotin-
amide is breaking, the ribose ring would be expected to
flatten, drawing the C10 position closer to the acetyl ly-
sine carbonyl. A motion of about 1.8 A˚ would be required
of the C10 atom to break the bond with nicotinamide and
form a bond with the acetyl oxygen, leading to formation
of an O-alkylamidate intermediate. These movements
can be readily accommodated in the Sir2 active site.
Once the intermediate has been formed, the invariant
active site histidine (His116 in Sir2Tm) is in a position to
activate the 20 OH of the N-ribose, either directly or by
a proton transfer relay mechanism through the 30 OH.
The activated 20 oxygen can then attack the acetyl
group, leading to formation of the final reaction products.
His116 hydrogen bonds to both the 20 and 30 hydroxyls in
the ternary complex and could readily serve as a general
base in the reaction. Studies have shown that the muta-
tion of the corresponding histidine in yeast Hst2 to
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exchange (Min et al., 2001), consistent with the above-
described mechanism. However, we find here that the
same substitution in Sir2Tm only slightly decreases en-
zymatic turnover, while substitution of His116 with tyro-
sine lowers activity about 10-fold. In a His/Ala mutation
of yeast Hst2, it has been shown that a fraction of NAD+
hydrolysis leads to water-mediated attack on theO-alky-
lamidate intermediate (Smith and Denu, 2006), and this is
likely to be the case with Sir2Tm mutants as well. How-
ever, structural studies on Sir2Tm mutants, as well as
biochemical studies on an Hst2 mutant, show that de-
acetylation does occur in the absence of this histidine.
It is possible that, in some enzymes, either the hydroxide
ion or another side chain may serve as an alternative
base in the reaction.
The invariantflexible loopresiduePhe33appears toplay
a critical role both in the initial reaction steps and in the
inhibitory nicotinamide exchange reaction (Armstrong
et al., 2002). In the ternary complex, the side chain of
Phe33 helps to shield the glycosidic bond from water
and is in a position to protect the developing oxacarbe-
nium transition state from hydrolysis. The location of this
residue in the flexible loop allows it to change position
with the movement of the ribose, as is seen in structures
of sirtuins bound to ADP ribose or in the absence of
NAD+ (Avalos et al., 2002, 2004; Min et al., 2001). We also
note that the phenyl ring stacks above the ribose ring
oxygen, with distances of 3.0–4.4 A˚ between the ribose
oxygen and the ring carbon atoms, which could allow for
pi-electron stabilization of the transient carbocation (Zhu
et al., 2003). The importance of Phe33 in the sirtuin deace-
tylation reaction has been demonstrated by studies show-
ing that mutation of the corresponding residue in yeast
Sir2 leads to a 90% decrease in deacetylation activity
and a loss of silencing in vivo (Armstrong et al., 2002).
The orientation of Phe33 is also likely to be a key mediator
of thenicotinamide exchange reaction (Avalos et al., 2005).
OncetheO-alkylamidate intermediatehasbeengenerated
and nicotinamide has diffused away, free nicotinamide
can rebind in the C pocket and react with the intermediate,
a base-exchange reaction that reforms NAD+ at the ex-
pense of the deacetylation reaction (Jackson et al., 2003;
Sauve and Schramm, 2003). In the product structure of
Sir2TmH116A presentedhere, as well as in previously deter-
mined sirtuinstructurescontainingADPribose(Zhaoetal.,
2003b) or nicotinamide (Avalos et al., 2005), the side chain
of Phe33 is shifted from its position in the ternary complex
above the ribose oxygen to a position adjacent to the
ribose C10 position. In this orientation, Phe33 occludes
the nicotinamide bound in the hydrophobic C pocket
from the O-acetyl ADP ribose bound in the NAD+. This
positioning has been postulated to block the cleaved
nicotinamide for reacting with the O-alkylamidate inter-
mediate (Avalos et al., 2005). Detailed kinetic and struc-
tural analysis of enzymes containing mutations of this in-
variant residue are required to determine its importance
for intermediate formation as well as base exchange.
Experimental Procedures
Protein Expression and Purification
The wild-type Sir2Tm enzyme from Thermatoga maritima and mu-
tants were expressed in E. coli and purified as described previously(Smith et al., 2002). The mutagenesis of Sir2Tm was carried out by
using QuickChange (Stratagene) mutagenesis.
Crystallization of Sirtuin-Substrate Ternary Complexes
Purified Sir2Tm and Sir2TmH116Y were dialyzed against 20 mM
HEPES (pH 7.4) and concentrated to 16 mg/ml. Sir2Tm protein was
combined with 5 ml of 40 mM acetylated p53 peptide (372-KKGQSTS
RHK-K[Ac]-LMFKTEG-389) to a final concentration of 10 mg/ml pro-
tein and 4 mM peptide. Crystals were grown by hanging drop vapor
diffusion in 100 mM CHES (pH 9.5–9.6) and 15% PEG 3350. Crystals
were soaked in cryoprotectant containing 20% PEG 3350, 100 mM
CHES (pH 9.5), and 10 mM NAD+ for a duration of 1 min to 16 hr
and were then flash frozen and stored in liquid nitrogen until use.
Crystals formed in space group P212121 with approximate unit cell di-
mensions of a = 46.1 A˚, b = 59.8 A˚, and c = 106 A˚ and were unaltered
by the presence of NAD+ in the cryoprotectant.
Crystallization of the Sirtuin-Deacetylated
Peptide Products Structure
Purified Sir2TmH116A was dialyzed against 20 mM HEPES (pH 7.4)
and concentrated to 16 mg/ml. Sir2TmH116A protein was combined
with 5 ml of 50 mM acetylated p53 peptide (372-KKGQSTSRHK-
K[Ac]-LMFKTEG-389) and 5 ml of 100 mM NAD+ (neutralized to pH
7.3) to give a final concentration of 10 mg/ml protein, 5 mM peptide,
and 10 mM NAD+. Crystals were grown by hanging drop vapor diffu-
sion in 11% PEG 8000, 100 mM sodium tartrate/potassium phos-
phate (pH 5.1–5.2), 200 mM NaCl and were dependent on the pres-
ence of peptide and NAD+. Crystals were soaked in cryoprotectant
containing 15% PEG 8000, 100 mM sodium tartrate/potassium
phosphate (pH 5.1), 200 mM NaCl, and 10 mM NAD+, flash frozen,
and stored in liquid nitrogen until use. Crystals formed in space
group P41 with approximate unit cell dimensions of a = 47.0 A˚, b =
47.0 A˚, and c = 257.1 A˚.
Structure Determination
Diffraction data from Sir2TmH116Y and wild-type Sir2Tm crystals
soaked with NAD+ were recorded at BioCars beamlines 14C and
14D and GM/CA beamline 23D at the Advance Photon Source
(APS) with a Quantum CCD detector and were reduced with
HKL2000 (Otwinowski and Minor, 1997) and CCP4 (CCP4, 1994).
The crystals are isomorphous to the structure of Sir2Tm bound to
the acetylated p53 peptide and nicotinamide (Avalos et al., 2005),
which was used to calculate initial phases, compute a Fourier differ-
ence map with CNS (Brunger et al., 1998), and locate the density cor-
responding to NAD+. The structure was built with O (Jones et al.,
1991) and refined with simulated annealing and energy minimization
in CNS. The final round of refinement was done by using the program
REFMAC5 from the CCP4 suite of programs. Residues 36–46, 37–43,
and 33–44 of the flexible loops of Sir2TmH116Y, Sir2Tm ternary, and
Sir2Tm products, respectively, showed no corresponding electron
density, indicating that this region is disordered. The final wild-
type ternary complex model contains 1 monomer of Sir2Tm, 9 resi-
dues from the acetylated p53 peptide, 1 NAD+ molecule, 1 zinc
molecule, and 98 waters. The structure of the Sir2TmH116Y ternary
complex contains 1 monomer of Sir2TmH116Y, 8 residues from the
acetylated p53 peptide, 1 NAD+ molecule, 1 zinc molecule, and
103 waters. The Sir2Tm-deacetylated peptide structure that re-
sulted from overnight soaks in the presence of NAD+ contained 1
molecule of Sir2Tm, 11 residues of the p53 peptide, 1 zinc molecule,
and 138 waters.
Diffraction data from Sir2TmH116A crystals grown in the presence
of acetylated p53 peptide and NAD+ were collected on beamline
GM/CA-CAT 24D at the Advance Photon Source (APS) with a Quan-
tum CCD detector and were reduced with HKL2000 (Otwinowski and
Minor, 1997) and CCP4 (CCP4, 1994). Initial phases were obtained
by molecular replacement (MolRep) (Vagin and Teplyakov, 1997)
by using the Rossmann fold domain of Sir2Tm as a search model.
After rigid body refinement of two Rossmann fold domains in the
asymmetric unit, the Zn binding domain was placed with EPMR (Kis-
singer et al., 2001). The structure was built by using O (Jones et al.,
1991) and was refined with rigid body refinement, simulated anneal-
ing, and energy minimization in CNS. The final round of refinement
was done by using the program REFMAC5 from the CCP4 suite
of programs. The final structure contained 2 monomers of Sir2Tm,
Structure
12402 p53 peptide molecules of 6 residues, 1 molecule of ADP ribose, 1
molecule 30-O-acetyl ADP ribose, 2 zinc atoms, and 215 waters.
Enzymatic Assays
Sir2Tm deacetylation activity was determined by monitoring the
consumption of NAD+ in a coupled assay as previously described
(Avalos et al., 2004, 2005).
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